| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
|
Nat Med
|
2006
|
24.38
|
|
2
|
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.
|
J Exp Med
|
2006
|
8.41
|
|
3
|
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.
|
J Infect Dis
|
2009
|
6.17
|
|
4
|
Towards an HIV cure: a global scientific strategy.
|
Nat Rev Immunol
|
2012
|
5.52
|
|
5
|
Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
|
Science
|
2004
|
5.31
|
|
6
|
Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture.
|
Am J Pathol
|
2002
|
3.66
|
|
7
|
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group.
|
J Acquir Immune Defic Syndr
|
2012
|
2.95
|
|
8
|
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.
|
J Infect Dis
|
2010
|
2.37
|
|
9
|
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
|
J Infect Dis
|
2006
|
2.26
|
|
10
|
Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study.
|
Anal Chem
|
2008
|
2.12
|
|
11
|
Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease.
|
AIDS
|
2002
|
2.02
|
|
12
|
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes.
|
J Infect Dis
|
2003
|
1.97
|
|
13
|
Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.
|
Nat Med
|
2002
|
1.93
|
|
14
|
Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates.
|
Blood
|
2012
|
1.91
|
|
15
|
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
|
Arch Intern Med
|
2007
|
1.84
|
|
16
|
HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation.
|
Proc Natl Acad Sci U S A
|
2003
|
1.71
|
|
17
|
Interleukin-7-treated naive T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1.
|
Blood
|
2002
|
1.70
|
|
18
|
Treatment of intestinal worms is associated with decreased HIV plasma viral load.
|
J Acquir Immune Defic Syndr
|
2002
|
1.59
|
|
19
|
Early immune senescence in HIV disease.
|
Curr HIV/AIDS Rep
|
2010
|
1.58
|
|
20
|
CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus.
|
J Infect Dis
|
2008
|
1.49
|
|
21
|
Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics.
|
Nature
|
2006
|
1.48
|
|
22
|
Whole-blood interleukin-18 level during early HIV-1 infection is associated with reduced CXCR4 coreceptor expression and interferon- gamma levels.
|
J Infect Dis
|
2007
|
1.42
|
|
23
|
Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.
|
J Infect Dis
|
2010
|
1.42
|
|
24
|
Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
|
Clin Vaccine Immunol
|
2007
|
1.41
|
|
25
|
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.
|
AIDS Res Hum Retroviruses
|
2012
|
1.35
|
|
26
|
Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
|
J Infect Dis
|
2006
|
1.32
|
|
27
|
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.
|
J Infect Dis
|
2006
|
1.31
|
|
28
|
CD4 immunophenotyping in HIV infection.
|
Nat Rev Microbiol
|
2008
|
1.27
|
|
29
|
Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.
|
J Virol
|
2006
|
1.23
|
|
30
|
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response.
|
J Infect Dis
|
2004
|
1.21
|
|
31
|
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.
|
Antivir Ther
|
2007
|
1.17
|
|
32
|
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.
|
J Infect Dis
|
2012
|
1.17
|
|
33
|
Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication.
|
J Clin Invest
|
2014
|
1.14
|
|
34
|
Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics.
|
Nature
|
2006
|
1.13
|
|
35
|
Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.
|
J Infect Dis
|
2003
|
1.11
|
|
36
|
The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection.
|
J Acquir Immune Defic Syndr
|
2008
|
1.10
|
|
37
|
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.
|
AIDS
|
2009
|
1.09
|
|
38
|
A North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): a NIAID-DAIDS Immunology Quality Assessment Program Study.
|
Cytometry B Clin Cytom
|
2008
|
1.06
|
|
39
|
Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.
|
PLoS One
|
2012
|
1.06
|
|
40
|
Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial.
|
AIDS
|
2011
|
1.05
|
|
41
|
The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.
|
Curr HIV Res
|
2012
|
1.05
|
|
42
|
HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course.
|
J Acquir Immune Defic Syndr
|
2003
|
1.05
|
|
43
|
Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy.
|
AIDS
|
2004
|
1.03
|
|
44
|
MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study.
|
J Acquir Immune Defic Syndr
|
2003
|
1.01
|
|
45
|
Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms.
|
J Acquir Immune Defic Syndr
|
2004
|
1.01
|
|
46
|
CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection.
|
Immunology
|
2003
|
1.01
|
|
47
|
Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8⁺ T cell function in vitro.
|
J Leukoc Biol
|
2013
|
1.01
|
|
48
|
Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease.
|
J Infect Dis
|
2005
|
1.00
|
|
49
|
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.
|
J Infect Dis
|
2012
|
0.98
|
|
50
|
Immune responses to abacavir in antigen-presenting cells from hypersensitive patients.
|
AIDS
|
2007
|
0.96
|
|
51
|
HIV type 1 and cytomegalovirus coinfection in the female genital tract.
|
J Infect Dis
|
2004
|
0.95
|
|
52
|
Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial.
|
AIDS
|
2015
|
0.95
|
|
53
|
Immunophenotypic alterations in acute and early HIV infection.
|
Clin Immunol
|
2007
|
0.94
|
|
54
|
Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells.
|
AIDS
|
2007
|
0.94
|
|
55
|
Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.
|
Virology
|
2007
|
0.93
|
|
56
|
Chemokine analogues show suitable stability for development as microbicides.
|
J Acquir Immune Defic Syndr
|
2008
|
0.93
|
|
57
|
Intracellular Casp8p41 content is inversely associated with CD4 T cell count.
|
J Infect Dis
|
2010
|
0.93
|
|
58
|
GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals.
|
PLoS One
|
2012
|
0.92
|
|
59
|
Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection.
|
AIDS
|
2014
|
0.92
|
|
60
|
Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infection.
|
J Acquir Immune Defic Syndr
|
2007
|
0.91
|
|
61
|
Longitudinal assessment of pigtailed macaque lower genital tract microbiota by pyrosequencing reveals dissimilarity to the genital microbiota of healthy humans.
|
AIDS Res Hum Retroviruses
|
2012
|
0.91
|
|
62
|
Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s.
|
J Infect Dis
|
2003
|
0.90
|
|
63
|
Role of Baseline pol Genotype in HIV-1 Fitness Evolution.
|
J Acquir Immune Defic Syndr
|
2003
|
0.89
|
|
64
|
Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy.
|
AIDS
|
2007
|
0.89
|
|
65
|
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection.
|
AIDS
|
2002
|
0.88
|
|
66
|
Dynamics of cytokine expression in HIV productively infected primary CD4+ T cells.
|
Blood
|
2004
|
0.88
|
|
67
|
Interleukin-7 induces HIV replication in primary naive T cells through a nuclear factor of activated T cell (NFAT)-dependent pathway.
|
Virology
|
2006
|
0.87
|
|
68
|
Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.
|
AIDS Res Hum Retroviruses
|
2010
|
0.86
|
|
69
|
Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cells.
|
Immunology
|
2005
|
0.86
|
|
70
|
The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions.
|
J Infect Dis
|
2002
|
0.86
|
|
71
|
GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals.
|
AIDS
|
2013
|
0.86
|
|
72
|
Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction.
|
AIDS
|
2013
|
0.85
|
|
73
|
Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328).
|
AIDS Res Ther
|
2010
|
0.84
|
|
74
|
Immune recovery in HIV disease: role of the thymus and T cell expansion in immune reconstitution strategies.
|
J Hematother Stem Cell Res
|
2002
|
0.84
|
|
75
|
Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load.
|
AIDS
|
2002
|
0.83
|
|
76
|
CCR5 and CXCR4 expression after highly active antiretroviral therapy (HAART).
|
J Acquir Immune Defic Syndr
|
2002
|
0.82
|
|
77
|
Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach.
|
AIDS
|
2013
|
0.82
|
|
78
|
Trophoblasts are productively infected by CD4-independent isolate of HIV type 1.
|
AIDS Res Hum Retroviruses
|
2002
|
0.82
|
|
79
|
Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group.
|
Clin Infect Dis
|
2003
|
0.81
|
|
80
|
Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
|
J Infect Dis
|
2003
|
0.81
|
|
81
|
Biology of mucosally transmitted sexual infection-translating the basic science into novel HIV intervention: a workshop summary.
|
AIDS Res Hum Retroviruses
|
2012
|
0.80
|
|
82
|
A role for TLR signaling during B cell activation in antiretroviral-treated HIV individuals.
|
AIDS Res Hum Retroviruses
|
2013
|
0.80
|
|
83
|
Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women.
|
AIDS Res Hum Retroviruses
|
2008
|
0.80
|
|
84
|
HIV infection of primary CD4+ Th2 cells, defined by expression of the chemoattractant receptor-homologous (CRTH2), induces a Th0 phenotype.
|
AIDS Res Hum Retroviruses
|
2007
|
0.79
|
|
85
|
The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women.
|
Viral Immunol
|
2014
|
0.78
|
|
86
|
Effector and regulatory roles for B cells in HIV infection?
|
Autoimmunity
|
2012
|
0.78
|
|
87
|
Research needs and challenges in the development of HIV diagnostic and treatment monitoring tests for use in resource-limited settings.
|
Curr Opin HIV AIDS
|
2008
|
0.78
|
|
88
|
Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection.
|
J Infect Dis
|
2012
|
0.78
|
|
89
|
Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function.
|
AIDS
|
2004
|
0.78
|
|
90
|
Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities.
|
Curr HIV/AIDS Rep
|
2015
|
0.78
|
|
91
|
Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.
|
Clin Diagn Lab Immunol
|
2005
|
0.77
|
|
92
|
Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine.
|
Clin Vaccine Immunol
|
2009
|
0.77
|
|
93
|
Systemic Immune Activation and HIV Shedding in the Female Genital Tract.
|
J Acquir Immune Defic Syndr
|
2016
|
0.77
|
|
94
|
Key Concepts in the Early Immunology of HIV-1 Infection.
|
Curr Infect Dis Rep
|
2012
|
0.76
|
|
95
|
A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment.
|
J Interferon Cytokine Res
|
2011
|
0.76
|
|
96
|
Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
|
J Acquir Immune Defic Syndr
|
2016
|
0.75
|
|
97
|
Loneliness in Older Black Adults with Human Immunodeficiency Virus Is Associated with Poorer Cognition.
|
Gerontology
|
2017
|
0.75
|
|
98
|
Liver X receptor alpha (LXRalpha) as a therapeutic target in chronic lymphocytic leukemia (CLL).
|
J Leukoc Biol
|
2009
|
0.75
|
|
99
|
Monitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimen.
|
AIDS Res Ther
|
2005
|
0.75
|
|
100
|
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
|
PLoS Pathog
|
2016
|
0.75
|
|
101
|
Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma.
|
AIDS
|
2015
|
0.75
|
|
102
|
HIV immunology better understood and vaccination attempts started.
|
AIDS
|
2002
|
0.75
|
|
103
|
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
|
PLoS Pathog
|
2017
|
0.75
|
|
104
|
Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens.
|
J Acquir Immune Defic Syndr
|
2002
|
0.75
|